Venus Remedies (VENUSREM) Shareholding Pattern

NSE: VENUSREM • Promoter, FII, DII Holdings for Tickjournal
Promoter Holding 41.76%
FII Holding 2.26%
DII Holding 1.03%
Public Holding 45.16%
Total Shareholders 18,606
As of Dec 2025
View the latest shareholding pattern of Venus Remedies (VENUSREM) including promoter, FII, DII, and public holdings. Track VENUSREM ownership changes over time and document your investment thesis in Tickjournal — your personal trade journal. (See Venus Remedies intrinsic worth)

Venus Remedies (VENUSREM) Shareholding Summary

  • Promoter holding remains unchanged at 41.76% in Dec 2025
  • FII/FPI have increased holdings from 1.86% to 2.26% in Dec 2025
  • DIIs have increased holdings from 0.75% to 1.03% in Dec 2025
  • Institutional investors have increased holdings from 2.61% to 3.29% in Dec 2025
  • Public holding has decreased from 45.30% to 45.16% in Dec 2025
  • Number of shareholders increased from 17,725 to 18,606 in Dec 2025

VENUSREM Quarterly Ownership Changes

Quarter-over-quarter changes for Venus Remedies from Sept 2025 to Dec 2025.

Promoter Holding Change
Sept 2025 to Dec 2025
No Change
FII Holding Change
Sept 2025 to Dec 2025
+0.4%
DII Holding Change
Sept 2025 to Dec 2025
+0.28%
Public Holding Change
Sept 2025 to Dec 2025
-0.14%

Venus Remedies (VENUSREM) Quarterly Shareholding Trends

Visual breakdown of VENUSREM ownership distribution over time. Learn more about VENUSREM complete financial.

Promoter
FII
DII
Public
Government

Rising institutional holdings in VENUSREM often correlate with improved fundamentals. Check out VENUSREM annual price range.

Venus Remedies (VENUSREM) Shareholding Data

Download complete VENUSREM ownership data for offline analysis. Discover Venus Remedies P/E valuation.

Period Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 41.76% 2.26% 1.03% 0.00% 45.16% 9.80% 100.01% 18,606
Sept 2025 41.76% 1.86% 0.75% 0.00% 45.30% 10.33% 100.00% 17,725
Jun 2025 41.76% 2.24% 0.11% 0.00% 47.70% 8.19% 100.00% 19,307
Mar 2025 41.76% 1.34% 0.00% 0.00% 46.81% 10.09% 100.00% 19,982
Dec 2024 41.76% 1.11% 0.00% 0.00% 45.42% 11.71% 100.00% 19,771
Sept 2024 41.76% 1.18% 0.15% 0.00% 45.31% 11.61% 100.01% 19,557
Jun 2024 41.76% 1.06% 0.15% 0.00% 46.25% 10.78% 100.00% 19,614
Mar 2024 41.76% 1.48% 0.15% 0.00% 46.89% 9.73% 100.01% 19,913
Dec 2023 41.76% 1.59% 0.15% 0.00% 47.25% 9.24% 99.99% 19,560
Sept 2023 41.76% 1.03% 0.15% 0.00% 48.20% 8.86% 100.00% 19,267
Jun 2023 41.76% 0.00% 0.15% 0.00% 48.66% 9.43% 100.00% 20,498
Mar 2023 41.76% 0.00% 0.15% 0.00% 49.24% 8.85% 100.00% 21,719
Dec 2022 41.76% 0.00% 0.15% 0.00% 50.04% 8.05% 100.00% 22,243
Sept 2022 41.76% 0.00% 0.15% 0.00% 50.18% 7.91% 100.00% 22,015
Jun 2022 41.76% 0.00% 0.00% 0.00% 49.97% 8.27% 100.00% 21,189
Mar 2022 40.81% 0.00% 0.00% 0.00% 51.72% 7.48% 100.01% 19,952
Dec 2021 40.81% 0.00% 0.00% 0.00% 52.18% 7.01% 100.00% 18,231
Sept 2021 40.81% 0.00% 0.00% 0.00% 51.95% 7.24% 100.00% 16,617
Jun 2021 40.81% 0.00% 0.00% 0.00% 51.21% 7.98% 100.00% 13,846
Mar 2021 35.89% 0.00% 0.00% 0.00% 54.71% 9.39% 99.99% 13,829

VENUSREM promoter holding above 50% indicates strong insider confidence. Explore the VENUSREM quarterly trends for detailed insights.

Quarter Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 41.76% 2.26% 1.03% 0.00% 45.16% 9.80% 100.01% 18,606
Sept 2025 41.76% 1.86% 0.75% 0.00% 45.30% 10.33% 100.00% 17,725
Jun 2025 41.76% 2.24% 0.11% 0.00% 47.70% 8.19% 100.00% 19,307
Mar 2025 41.76% 1.34% 0.00% 0.00% 46.81% 10.09% 100.00% 19,982
Dec 2024 41.76% 1.11% 0.00% 0.00% 45.42% 11.71% 100.00% 19,771
Sept 2024 41.76% 1.18% 0.15% 0.00% 45.31% 11.61% 100.01% 19,557
Jun 2024 41.76% 1.06% 0.15% 0.00% 46.25% 10.78% 100.00% 19,614
Mar 2024 41.76% 1.48% 0.15% 0.00% 46.89% 9.73% 100.01% 19,913
Dec 2023 41.76% 1.59% 0.15% 0.00% 47.25% 9.24% 99.99% 19,560
Sept 2023 41.76% 1.03% 0.15% 0.00% 48.20% 8.86% 100.00% 19,267
Jun 2023 41.76% 0.00% 0.15% 0.00% 48.66% 9.43% 100.00% 20,498
Mar 2023 41.76% 0.00% 0.15% 0.00% 49.24% 8.85% 100.00% 21,719

Quarterly data helps track institutional investment cycles.

Year Promoter (%) FII (%) DII (%) Govt (%) Public (%) Other (%) Total (%) Shareholders
Dec 2025 41.76% 2.26% 1.03% 0.00% 45.16% 9.80% 100.01% 18,606
Dec 2024 41.76% 1.11% 0.00% 0.00% 45.42% 11.71% 100.00% 19,771
Dec 2023 41.76% 1.59% 0.15% 0.00% 47.25% 9.24% 99.99% 19,560
Dec 2022 41.76% 0.00% 0.15% 0.00% 50.04% 8.05% 100.00% 22,243
Dec 2021 40.81% 0.00% 0.00% 0.00% 52.18% 7.01% 100.00% 18,231

Year-over-year trends reveal long-term ownership shifts.

Understanding Venus Remedies (VENUSREM) Shareholding Pattern

Venus Remedies shareholding pattern reveals who owns VENUSREM stock and how ownership changes over time. High promoter stakes in VENUSREM often signal management confidence, while rising FII/DII holdings suggest growing institutional interest. Use Tickjournal to log these insights alongside your VENUSREM trades. Venus Remedies market worth

Combine VENUSREM ownership analysis with price movements and financial performance for a complete investment picture. (See VENUSREM book value comparison)